Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
CVR Energy has gained 12.5% in a single week and 29% over the past month, a run so sharp it has left the Street's price targets scrambling to catch up and brought Q3 earnings squarely into focus.
The analyst picture captures the awkward position the stock has put its coverage in. Despite two consecutive target-price upgrades in the past week, the consensus points to meaningful downside from current levels. Mizuho lifted its target from $29 to $52 this morning while holding an Underperform rating. UBS raised its target from $35 to $53 six days ago while keeping Neutral. Goldman Sachs carries a Sell. The mean price target across coverage is $37.60, more than $19 below Wednesday's close of $57.38. Even after an aggressive round of catch-up revisions, the Street collectively still sees the stock as roughly a third too expensive. EPS momentum has been exceptional, ranking in the 100th percentile on a 30-day basis and the 96th on 90 days, but EPS surprise sits in just the 5th percentile, a reminder that recent earnings have not been beating expectations, they have simply benefited from sharply rising forward estimates. The PE multiple has compressed by 11.4 points over the past 30 days as earnings estimates have been marked up faster than the price was rising; the price then caught up violently this week, lifting the PE back to 18.6x.
Positioning in the lending market offers no support for the bear case in the near term. Availability is generous at 629%, meaning roughly six shares remain available to borrow for every one already lent out. The 52-week low availability was 188%, and even that was loose by any short-squeeze standard. Cost to borrow is 0.43%, down about 12% on the week and well within the range that makes new short exposure cheap and easy to put on. Short interest as measured by ORTEX is a modest 5.6 million shares, down about 5% over the past month and essentially flat across the past week. There is no mechanical pressure on existing shorts. Options sentiment is mildly constructive. The put/call ratio at 0.68 is slightly below its 20-day average of 0.70, a hair below neutral, and well within the year's range of 0.22 to 1.21. Nothing in the derivatives market signals either strong conviction or unusual hedging ahead of earnings.
The ownership structure gives CVI one of the cleaner controlling-shareholder stories in US equities. Carl Icahn, through Icahn Enterprises Holdings, holds 70.8% of the company as of his last 13D/A filed in February, having stepped up the stake from 69.8%. That February filing came alongside three open-market purchases totalling $16.4 million in net value at prices between $20.75 and $21.41, less than half where the stock trades today. The stake is so large that the free float available to institutional and retail buyers is a fraction of the share count, which helps explain why short interest as a percentage of float carries limited analytical weight here. BlackRock added 410,000 shares in the most recent quarter, reaching 5.2% of shares. State Street and Dimensional also added modestly. The broader institutional holder count is just 145, thin for a name trading near $57.
CVR reports Q3 results on October 26. The most recent comparable earnings event, July 30, produced a 2.9% gain on the day followed by a 9.4% pullback over the subsequent five sessions, a pattern that has been roughly consistent across the available history. The stock enters that release up nearly 30% in a month, at a price level that sits above every sell-side target on the Street.
The key question into the October 26 print is less about whether refining margins held and more about whether management's guidance narrows the gap between the current price and analyst fair value estimates, or widens it further.
See the live data behind this article on ORTEX.
Open CVI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
